The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
In a move that intensifies the pressure on dry bulk shipping boards, proxy advisory firm ISS has recommended that Genco Shipping & Trading shareholders vote against the company's 'poison pill' defense. This recommendation comes amid an escalating takeover battle, as Diana Shipping seeks to install independent nominees on Genco's board and dismantle defensive measures that hinder the evaluation of its all-cash offer. According to reports, ISS believes the rights plan could serve to entrench incumbent management and unfairly limit shareholders' ability to consider external acquisition proposals.
Sign in to access this content
Sign InThe conflict centers on Diana Shipping's recently increased offer of $24.80 per share in cash, valuing the deal at approximately $1.43 billion per market data. In comparison, Genco (GNK) shares closed at $24.69 on June 5, 2026, while Diana Shipping (DSX) stood at $2.39 as of June 11, 2026 (per market data). Other advisory firms, including Glass Lewis, have voiced similar concerns regarding the potential for the rights plan to restrict shareholders from evaluating serious bids, despite supporting Genco's current director nominees.
Traders should closely watch Genco's annual shareholder meeting scheduled for June 18, 2026, which is expected to be a decisive catalyst for the takeover's fate and board composition. Additionally, Diana Shipping's tender offer is currently set to expire on June 26, 2026, unless further extended. On the macro front, market participants are also monitoring global trade dynamics following trade balance data from Germany and the US on June 9, 2026, which may impact sentiment across the dry bulk sector.